Penn Memory Center
@pennmemorycenter.bsky.social
A Penn Medicine organization evaluating, diagnosing and researching Alzheimer's disease and related diseases.
Who’s pushing the boundaries of Alzheimer’s research?
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
September 10, 2025 at 5:15 PM
Who’s pushing the boundaries of Alzheimer’s research?
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
Who’s pushing the boundaries of Alzheimer’s research?
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
August 14, 2025 at 7:06 PM
Who’s pushing the boundaries of Alzheimer’s research?
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
What breakthroughs are shaping the future?
Get the inside story in inSight, the Penn Memory Center’s biweekly newsletter.
Sign up for updates on science, care, and hope: bit.ly/PMC-InSight
All adults with Down syndrome develop Alzheimer’s pathology by age 40, yet were long excluded from trials.
Dr. Michael Rafii is changing that, building a pipeline of inclusive research from biomarkers to global studies.
Learn more about his work: bit.ly/46pljnv
Dr. Michael Rafii is changing that, building a pipeline of inclusive research from biomarkers to global studies.
Learn more about his work: bit.ly/46pljnv
July 23, 2025 at 3:41 PM
All adults with Down syndrome develop Alzheimer’s pathology by age 40, yet were long excluded from trials.
Dr. Michael Rafii is changing that, building a pipeline of inclusive research from biomarkers to global studies.
Learn more about his work: bit.ly/46pljnv
Dr. Michael Rafii is changing that, building a pipeline of inclusive research from biomarkers to global studies.
Learn more about his work: bit.ly/46pljnv